This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Foundation for Biomedical Research and Innovation, Kyoto Prefectural Public University Corporation. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2022
Title: The Innovative Contributions of Seiichi Yokoo
Introduction
Seiichi Yokoo is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of biomedical research, particularly in the area of cell culture technology. His innovative methods have the potential to advance medical treatments and regenerative medicine.
Latest Patents
Yokoo holds a patent for a "Method for producing cultivated epithelial cell sheet." This method involves culturing cells derived from oral mucosal epithelial cells on a substrate in a serum-free medium. The serum-free medium comprises epidermal growth factor (EGF) or keratinocyte growth factor (KGF), a B-27 supplement, and a ROCK inhibitor. This innovative approach is crucial for developing epithelial cell sheets that can be used in various medical applications.
Career Highlights
Throughout his career, Seiichi Yokoo has worked with esteemed institutions such as the Kyoto Prefectural Public University Corporation and the Foundation for Biomedical Research and Innovation at Kobe. His work in these organizations has allowed him to contribute to significant advancements in biomedical research.
Collaborations
Yokoo has collaborated with notable colleagues, including Takahiro Nakamura and Shigeru Kinoshita. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Seiichi Yokoo's contributions to the field of biomedical research through his innovative patent and collaborations highlight his importance as an inventor. His work continues to influence advancements in medical technology and regenerative medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile